Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
172 participants
OBSERVATIONAL
2013-11-30
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Proteomic Profiling of Coronary Thrombus in Acute Myocardial Infarction
NCT03731884
Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis at Different Time
NCT03137212
Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?
NCT00483587
Thrombus Aspiration in Acute ST-elevation Myocardial Infarction
NCT02746822
Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
NCT03406819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age\>18 y/o
Exclusion Criteria
* LBB, RBB
* Renal Insuffiency MDRD\<30 mL/min
* Patient with Pace-Maker or ICD.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick OHLMANN, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Strasbourg, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5515
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.